Yuan‐Tso Cheng
Papers
1
Total Citations
11
H-Index
1
About
Yuan-Tso Cheng is a leading urologic surgeon and researcher specializing in minimally invasive treatments for renal tumors, with a particular focus on nephron-sparing surgery and ablative techniques. His major contributions center on comparing the long-term outcomes of robot-assisted laparoscopic partial nephrectomy (RaPN) and laparoscopic cryoablation for localized renal tumors, providing critical evidence to guide clinical decision-making. His landmark 2021 propensity score-matched study, cited 11 times, demonstrated that while cryoablation remains the recommended treatment for clinical T1a stage tumors, RaPN offers superior oncological control for appropriately selected patients. This work has helped refine treatment algorithms for renal neoplasms, balancing the dual imperatives of preserving renal function and achieving optimal cancer control. Cheng’s research directly addresses the challenging clinical question of which minimally invasive approach yields the best long-term outcomes for patients with localized disease. His findings have been influential in urologic oncology, shaping how surgeons weigh the benefits of partial nephrectomy versus ablation. Through his comparative effectiveness research, Cheng continues to advance the field of robotic urologic surgery, helping to establish evidence-based standards for the management of small renal masses.
Research Focus
Key Achievements
Top Papers
- 1